Macular telangiectasia type 1 managed with long-term aflibercept therapy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A 60-year-old man diagnosed with macular telangiectasia type 1 (MacTel 1) was treated for 3 years with monthly aflibercept (Eylea; Regeneron, Tarrytown, NY) and serially imaged with spectral-domain optical coherence tomography. When administered monthly, aflibercept appeared to have a beneficial effect on macular edema secondary to MacTel 1. Visual acuity preservation despite minimal chronic macular edema could be attributed to the lack of significant photoreceptor disruption.

Original languageEnglish (US)
Pages (from-to)593-595
Number of pages3
JournalOphthalmic Surgery Lasers and Imaging Retina
Volume47
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Telangiectasis
Macular Edema
Optical Coherence Tomography
Visual Acuity
Therapeutics
aflibercept

ASJC Scopus subject areas

  • Ophthalmology
  • Surgery

Cite this

Macular telangiectasia type 1 managed with long-term aflibercept therapy. / Kovach, Jaclyn; Hess, Harald; Rosenfeld, Philip J.

In: Ophthalmic Surgery Lasers and Imaging Retina, Vol. 47, No. 6, 01.06.2016, p. 593-595.

Research output: Contribution to journalArticle

@article{5dfd59656e4e4153ae3bf3be8d82769e,
title = "Macular telangiectasia type 1 managed with long-term aflibercept therapy",
abstract = "A 60-year-old man diagnosed with macular telangiectasia type 1 (MacTel 1) was treated for 3 years with monthly aflibercept (Eylea; Regeneron, Tarrytown, NY) and serially imaged with spectral-domain optical coherence tomography. When administered monthly, aflibercept appeared to have a beneficial effect on macular edema secondary to MacTel 1. Visual acuity preservation despite minimal chronic macular edema could be attributed to the lack of significant photoreceptor disruption.",
author = "Jaclyn Kovach and Harald Hess and Rosenfeld, {Philip J}",
year = "2016",
month = "6",
day = "1",
doi = "10.3928/23258160-20160601-14",
language = "English (US)",
volume = "47",
pages = "593--595",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",
number = "6",

}

TY - JOUR

T1 - Macular telangiectasia type 1 managed with long-term aflibercept therapy

AU - Kovach, Jaclyn

AU - Hess, Harald

AU - Rosenfeld, Philip J

PY - 2016/6/1

Y1 - 2016/6/1

N2 - A 60-year-old man diagnosed with macular telangiectasia type 1 (MacTel 1) was treated for 3 years with monthly aflibercept (Eylea; Regeneron, Tarrytown, NY) and serially imaged with spectral-domain optical coherence tomography. When administered monthly, aflibercept appeared to have a beneficial effect on macular edema secondary to MacTel 1. Visual acuity preservation despite minimal chronic macular edema could be attributed to the lack of significant photoreceptor disruption.

AB - A 60-year-old man diagnosed with macular telangiectasia type 1 (MacTel 1) was treated for 3 years with monthly aflibercept (Eylea; Regeneron, Tarrytown, NY) and serially imaged with spectral-domain optical coherence tomography. When administered monthly, aflibercept appeared to have a beneficial effect on macular edema secondary to MacTel 1. Visual acuity preservation despite minimal chronic macular edema could be attributed to the lack of significant photoreceptor disruption.

UR - http://www.scopus.com/inward/record.url?scp=84983805460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983805460&partnerID=8YFLogxK

U2 - 10.3928/23258160-20160601-14

DO - 10.3928/23258160-20160601-14

M3 - Article

C2 - 27327292

AN - SCOPUS:84983805460

VL - 47

SP - 593

EP - 595

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

IS - 6

ER -